<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Repaglinide</title><link>http://www.unboundmedicine.com/medline/ebm/research/Repaglinide</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2mum particle size column.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19019380/full_citation/Analysis_of_nine_drugs_and_their_cytochrome_P450_specific_probe_metabolites_from_urine_by_liquid_chromatography_tandem_mass_spectrometry_utilizing_sub_2mum_particle_size_column_</link><description>Petsalo A, Turpeinen M, Pelkonen O, et al. <br/><span class="title">Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2mum particle size column. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of chromatography. A">J Chromatogr A 2008 Nov 7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19019380/abstract/Analysis_of_nine_drugs_and_their_cytochrome_P450_specific_probe_metabolites_from_urine_by_liquid_chromatography_tandem_mass_spectrometry_utilizing_sub_2mum_particle_size_column_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19019380/full_citation/Analysis_of_nine_drugs_and_their_cytochrome_P450_specific_probe_metabolites_from_urine_by_liquid_chromatography_tandem_mass_spectrometry_utilizing_sub_2mum_particle_size_column_">Full Citation</a></description></item><item><title>Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18854776/full_citation/Effects_of_the_SLCO1B1_1B_haplotype_on_the_pharmacokinetics_and_pharmacodynamics_of_repaglinide_and_nateglinide_</link><description>Kalliokoski A, Backman JT, Neuvonen PJ, et al. <br/><span class="title">Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide. [Journal Article]</span><br/><span class="source" title="Pharmacogenetics and genomics">Pharmacogenet Genomics 2008 Nov; 18(11):937-42.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18854776/abstract/Effects_of_the_SLCO1B1_1B_haplotype_on_the_pharmacokinetics_and_pharmacodynamics_of_repaglinide_and_nateglinide_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18854776/full_citation/Effects_of_the_SLCO1B1_1B_haplotype_on_the_pharmacokinetics_and_pharmacodynamics_of_repaglinide_and_nateglinide_">Full Citation</a></description></item><item><title>Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18844675/full_citation/Reversible_binding_of_antidiabetic_drugs_repaglinide_and_gliclazide_with_human_serum_albumin_</link><description>Seedher N, Kanojia M <br/><span class="title">Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin. [Journal Article]</span><br/><span class="source" title="Chemical biology &amp; drug design">Chem Biol Drug Des 2008 Oct; 72(4):290-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18844675/abstract/Reversible_binding_of_antidiabetic_drugs_repaglinide_and_gliclazide_with_human_serum_albumin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18844675/full_citation/Reversible_binding_of_antidiabetic_drugs_repaglinide_and_gliclazide_with_human_serum_albumin_">Full Citation</a></description></item><item><title>Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18825302/full_citation/Repaglinide_plus_single_dose_insulin_glargine:_a_safe_regimen_for_low_risk_type_2_diabetic_patients_who_insist_on_fasting_in_Ramadan_</link><description>Bakiner O, Ertorer ME, Bozkirli E, et al. <br/><span class="title">Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta diabetologica">Acta Diabetol 2008 Sep 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18825302/abstract/Repaglinide_plus_single_dose_insulin_glargine:_a_safe_regimen_for_low_risk_type_2_diabetic_patients_who_insist_on_fasting_in_Ramadan_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18825302/full_citation/Repaglinide_plus_single_dose_insulin_glargine:_a_safe_regimen_for_low_risk_type_2_diabetic_patients_who_insist_on_fasting_in_Ramadan_">Full Citation</a></description></item><item><title>The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18823304/full_citation/The_effect_of_SLCO1B1_polymorphism_on_repaglinide_pharmacokinetics_persists_over_a_wide_dose_range_</link><description>Kalliokoski A, Neuvonen M, Neuvonen PJ, et al. <br/><span class="title">The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2008 Sep 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18823304/abstract/The_effect_of_SLCO1B1_polymorphism_on_repaglinide_pharmacokinetics_persists_over_a_wide_dose_range_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18823304/full_citation/The_effect_of_SLCO1B1_polymorphism_on_repaglinide_pharmacokinetics_persists_over_a_wide_dose_range_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1365-2125.2008.03287.x">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18823304/The_effect_of_SLCO1B1_polymorphism_on_repaglinide_pharmacokinetics_persists_over_a_wide_dose_range_">Find Related Articles</a> </description></item><item><title>Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18777156/full_citation/Differential_lipid_profile_and_hormonal_response_in_type_2_diabetes_by_exogenous_insulin_aspart_versus_the_insulin_secretagogue_repaglinide_at_the_same_glycemic_control_</link><description>Chisalita SI, Lindström T, E Son Jennersjö P, et al. <br/><span class="title">Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta diabetologica">Acta Diabetol 2008 Sep 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18777156/abstract/Differential_lipid_profile_and_hormonal_response_in_type_2_diabetes_by_exogenous_insulin_aspart_versus_the_insulin_secretagogue_repaglinide_at_the_same_glycemic_control_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18777156/full_citation/Differential_lipid_profile_and_hormonal_response_in_type_2_diabetes_by_exogenous_insulin_aspart_versus_the_insulin_secretagogue_repaglinide_at_the_same_glycemic_control_">Full Citation</a></description></item><item><title>Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin : Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18666804/full_citation/Fixed_Dose_Combination_Tablet_of_Repaglinide_and_Metformin_is_Bioequivalent_to_Concomitantly_Administered_Individual_Tablets_of_Repaglinide_and_Metformin_:_Randomized_Single_Blind_Three_Period_Crossover_Study_in_Healthy_Subjects_</link><description>Hoelscher D, Chu PL, Lyness W <br/><span class="title">Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin : Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects. [Journal Article]</span><br/><span class="source" title="Clinical drug investigation">Clin Drug Investig 2008; 28(9):573-82.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18666804/abstract/Fixed_Dose_Combination_Tablet_of_Repaglinide_and_Metformin_is_Bioequivalent_to_Concomitantly_Administered_Individual_Tablets_of_Repaglinide_and_Metformin_:_Randomized_Single_Blind_Three_Period_Crossover_Study_in_Healthy_Subjects_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18666804/full_citation/Fixed_Dose_Combination_Tablet_of_Repaglinide_and_Metformin_is_Bioequivalent_to_Concomitantly_Administered_Individual_Tablets_of_Repaglinide_and_Metformin_:_Randomized_Single_Blind_Three_Period_Crossover_Study_in_Healthy_Subjects_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18666804/Fixed_Dose_Combination_Tablet_of_Repaglinide_and_Metformin_is_Bioequivalent_to_Concomitantly_Administered_Individual_Tablets_of_Repaglinide_and_Metformin_:_Randomized_Single_Blind_Three_Period_Crossover_Study_in_Healthy_Subjects_">Find Related Articles</a> </description></item><item><title>Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18664331/full_citation/Association_of_KCNJ11_and_ABCC8_genetic_polymorphisms_with_response_to_repaglinide_in_Chinese_diabetic_patients_</link><description>He YY, Zhang R, Shao XY, et al. <br/><span class="title">Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. [Journal Article]</span><br/><span class="source" title="Acta pharmacologica Sinica">Acta Pharmacol Sin 2008 Aug; 29(8):983-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18664331/abstract/Association_of_KCNJ11_and_ABCC8_genetic_polymorphisms_with_response_to_repaglinide_in_Chinese_diabetic_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18664331/full_citation/Association_of_KCNJ11_and_ABCC8_genetic_polymorphisms_with_response_to_repaglinide_in_Chinese_diabetic_patients_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18664331/Association_of_KCNJ11_and_ABCC8_genetic_polymorphisms_with_response_to_repaglinide_in_Chinese_diabetic_patients_">Find Related Articles</a> </description></item><item><title>Synthesis of hydantoin analogues of (2S,3R,4S)-4-hydroxyisoleucine with insulinotropic properties.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18621529/full_citation/Synthesis_of_hydantoin_analogues_of__2S3R4S__4_hydroxyisoleucine_with_insulinotropic_properties_</link><description>Sergent D, Wang Q, Sasaki NA, et al. <br/><span class="title">Synthesis of hydantoin analogues of (2S,3R,4S)-4-hydroxyisoleucine with insulinotropic properties. [JOURNAL ARTICLE]</span><br/><span class="source" title="Bioorganic &amp; medicinal chemistry letters">Bioorg Med Chem Lett 2008 Jun 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18621529/abstract/Synthesis_of_hydantoin_analogues_of__2S3R4S__4_hydroxyisoleucine_with_insulinotropic_properties_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18621529/full_citation/Synthesis_of_hydantoin_analogues_of__2S3R4S__4_hydroxyisoleucine_with_insulinotropic_properties_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18621529/Synthesis_of_hydantoin_analogues_of__2S3R4S__4_hydroxyisoleucine_with_insulinotropic_properties_">Find Related Articles</a> </description></item><item><title>Drugs for type 2 diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18583949/full_citation/Drugs_for_type_2_diabetes_</link><description><span class="title">Drugs for type 2 diabetes. [Journal Article]</span><br/><span class="source" title="Treatment guidelines from the Medical Letter">Treat Guidel Med Lett 2008 Jul; 6(71):47-54.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18583949/full_citation/Drugs_for_type_2_diabetes_">Full Citation</a></description></item></channel></rss>